Phase II sbir for process development and manufacture of an antibody-based therapy against marburgvirus.

Ended Definitive Contract Awarded Last action

Contract number
HDTRA120C0033
Awardee
Awarding agency
Obligated
$999,399

Award facts

Contract value 100% obligated
$999,398.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Frederick, MD 21701, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Sbir phase II manufacture of an antibody-based therapy against marburg virus. $0
Original award $999,399

About this award

This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Biofactura Inc., a small business manufacturer, for the process development and manufacture of an antibody-based therapy against Marburgvirus. The contract is a Firm Fixed Price Definitive Contract with a ceiling value of $999,398.93 and a period of performance ending on September 14, 2022. The contract is set aside for small businesses.

Quick answers

Who was awarded contract HDTRA120C0033?

HDTRA120C0033 was awarded to Biofactura Inc. by Defense Threat Reduction Agency (Department of Defense) on June 15, 2020.

How much is contract HDTRA120C0033 worth?

The government has obligated $999,399 on HDTRA120C0033.

Was contract HDTRA120C0033 competed?

The extent of competition for HDTRA120C0033 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award